Adagene Inc
F:978
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Adagene Inc (978) under the Base Case is 0.004 EUR per share.
Compared with the current market price of 1.39 EUR, the stock appears
Overvalued by 100% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Adagene Does
Adagene is a biotechnology company that designs and develops antibody-based cancer medicines. Its main work is to create therapeutic antibodies and move the most promising ones into clinical testing, rather than selling a finished drug portfolio today. The company’s science centers on making antibodies that are active only when they reach the right tumor environment, which is meant to improve how the drugs target cancer cells.
- Headquarters
- China CN
- Employees
- 128
- IPO date
- Feb 9, 2021
Continue Research
Decided on Adagene? Get an email when Adagene Inc reaches the price you’d buy at. Free with an account.
Other Adagene listings
What is the Intrinsic Value of one Adagene Inc stock?
The intrinsic value for
Adagene Inc (978) under the Base Case is 0.004 EUR.
Is Adagene Inc stock undervalued or overvalued?
Compared with the current market price of 1.39 EUR, the stock appears Overvalued by 100% .